Generation Bio Co.GBIOEarnings & Financial Report
Nasdaq
NextMar 13, 2026
GBIO Q3 2025 Key Financial Metrics
Revenue
$1.6M
Gross Profit
N/A
Operating Profit
$-6.7M
Net Profit
$-5.5M
Gross Margin
N/A
Operating Margin
-420.8%
Net Margin
-346.3%
YoY Growth
-78.9%
EPS
$-0.82
Financial Flow
Generation Bio Co. Q3 2025 Financial Summary
Generation Bio Co. reported revenue of $1.6M for Q3 2025, with a net profit of $-5.5M (-346.3% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $1.6M |
|---|---|
| Net Profit | $-5.5M |
| Gross Margin | N/A |
| Operating Margin | -420.8% |
| Report Period | Q3 2025 |
Generation Bio Co. Annual Revenue by Year
Generation Bio Co. annual revenue history includes year-by-year totals (for example, 2024 revenue was $19.9M).
| Year | Annual Revenue |
|---|---|
| 2024 | $19.9M |
| 2023 | $5.9M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9M | $4.1M | $4.1M | $7.6M | $4.2M | $8.7M | $765000 | $1.6M |
| YoY Growth | N/A | N/A | 364.9% | 252.0% | 45.5% | 114.9% | -81.3% | -78.9% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $374.8M | $285.9M | $265.3M | $248.8M | $231.2M | $201.3M | $179.4M | $121.9M |
| Liabilities | $171.6M | $153.9M | $149.9M | $144.3M | $145.0M | $128.0M | $125.3M | $71.3M |
| Equity | $203.1M | $132.0M | $115.4M | $104.4M | $86.2M | $73.3M | $54.1M | $50.6M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-25.0M | $-31.7M | $-21.5M | $-19.5M | $-15.8M | $-28.4M | $-16.8M | $-52.7M |